Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2012-09-06 21:03:48 UTC
Update Date2022-09-22 18:34:56 UTC
HMDB IDHMDB0029131
Secondary Accession Numbers
  • HMDB29131
Metabolite Identification
Common NameValylleucine
DescriptionValylleucine is a dipeptide composed of valine and leucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Structure
Data?1582753379
Synonyms
ValueSource
L-Val-L-leuChEBI
N-L-Valyl-L-leucineChEBI
Valyl-leucineChEBI
VLChEBI
L-Valyl-L-leucineHMDB
N-ValylleucineHMDB
V-L DipeptideHMDB
VL DipeptideHMDB
Val-leuHMDB
Valine leucine dipeptideHMDB
Valine-leucine dipeptideHMDB
ValylleucineChEBI
Chemical FormulaC11H22N2O3
Average Molecular Weight230.308
Monoisotopic Molecular Weight230.163042576
IUPAC Name(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanoic acid
Traditional Name(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanoic acid
CAS Registry Number3989-97-7
SMILES
CC(C)C[C@H](NC(=O)[C@@H](N)C(C)C)C(O)=O
InChI Identifier
InChI=1S/C11H22N2O3/c1-6(2)5-8(11(15)16)13-10(14)9(12)7(3)4/h6-9H,5,12H2,1-4H3,(H,13,14)(H,15,16)/t8-,9-/m0/s1
InChI KeyXCTHZFGSVQBHBW-IUCAKERBSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentDipeptides
Alternative Parents
Substituents
  • Alpha-dipeptide
  • Leucine or derivatives
  • Valine or derivatives
  • N-acyl-alpha-amino acid
  • N-acyl-l-alpha-amino acid
  • N-acyl-alpha amino acid or derivatives
  • Alpha-amino acid amide
  • Alpha-amino acid or derivatives
  • Branched fatty acid
  • Methyl-branched fatty acid
  • Fatty amide
  • N-acyl-amine
  • Fatty acyl
  • Fatty acid
  • Amino acid or derivatives
  • Carboxamide group
  • Carboxylic acid salt
  • Amino acid
  • Secondary carboxylic acid amide
  • Monocarboxylic acid or derivatives
  • Carboxylic acid
  • Organic salt
  • Hydrocarbon derivative
  • Amine
  • Primary aliphatic amine
  • Organic oxide
  • Organic oxygen compound
  • Organic nitrogen compound
  • Carbonyl group
  • Organopnictogen compound
  • Organonitrogen compound
  • Organooxygen compound
  • Primary amine
  • Organic zwitterion
  • Aliphatic acyclic compound
Molecular FrameworkAliphatic acyclic compounds
External Descriptors
Ontology
Not AvailableNot Available
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogP-1.24Extrapolated
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility8.65 g/LALOGPS
logP-1.2ALOGPS
logP-1.2ChemAxon
logS-1.4ALOGPS
pKa (Strongest Acidic)4.07ChemAxon
pKa (Strongest Basic)8.51ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area92.42 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity60.46 m³·mol⁻¹ChemAxon
Polarizability25.03 ųChemAxon
Number of Rings0ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+163.10430932474
DeepCCS[M-H]-160.74630932474
DeepCCS[M-2H]-193.63230932474
DeepCCS[M+Na]+169.19730932474

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022.2.19 minutes32390414
Predicted by Siyang on May 30, 202210.9393 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20226.12 minutes32390414
AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid168.9 seconds40023050
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid1321.9 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid219.9 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid103.5 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid151.7 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid64.8 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid330.4 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid351.3 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)132.4 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid708.6 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid340.1 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid1064.0 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid189.0 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid249.3 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate301.7 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA331.9 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water85.4 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
ValylleucineCC(C)C[C@H](NC(=O)[C@@H](N)C(C)C)C(O)=O2809.9Standard polar33892256
ValylleucineCC(C)C[C@H](NC(=O)[C@@H](N)C(C)C)C(O)=O1757.2Standard non polar33892256
ValylleucineCC(C)C[C@H](NC(=O)[C@@H](N)C(C)C)C(O)=O1751.3Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Valylleucine,1TMS,isomer #1CC(C)C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)O[Si](C)(C)C1777.4Semi standard non polar33892256
Valylleucine,1TMS,isomer #2CC(C)C[C@H](NC(=O)[C@@H](N[Si](C)(C)C)C(C)C)C(=O)O1813.6Semi standard non polar33892256
Valylleucine,1TMS,isomer #3CC(C)C[C@@H](C(=O)O)N(C(=O)[C@@H](N)C(C)C)[Si](C)(C)C1789.3Semi standard non polar33892256
Valylleucine,2TMS,isomer #1CC(C)C[C@H](NC(=O)[C@@H](N[Si](C)(C)C)C(C)C)C(=O)O[Si](C)(C)C1855.5Semi standard non polar33892256
Valylleucine,2TMS,isomer #1CC(C)C[C@H](NC(=O)[C@@H](N[Si](C)(C)C)C(C)C)C(=O)O[Si](C)(C)C1846.7Standard non polar33892256
Valylleucine,2TMS,isomer #2CC(C)C[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H](N)C(C)C)[Si](C)(C)C1793.6Semi standard non polar33892256
Valylleucine,2TMS,isomer #2CC(C)C[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H](N)C(C)C)[Si](C)(C)C1874.3Standard non polar33892256
Valylleucine,2TMS,isomer #3CC(C)C[C@@H](C(=O)O)N(C(=O)[C@@H](N[Si](C)(C)C)C(C)C)[Si](C)(C)C1835.3Semi standard non polar33892256
Valylleucine,2TMS,isomer #3CC(C)C[C@@H](C(=O)O)N(C(=O)[C@@H](N[Si](C)(C)C)C(C)C)[Si](C)(C)C1859.0Standard non polar33892256
Valylleucine,2TMS,isomer #4CC(C)C[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O1960.9Semi standard non polar33892256
Valylleucine,2TMS,isomer #4CC(C)C[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O1879.8Standard non polar33892256
Valylleucine,3TMS,isomer #1CC(C)C[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H](N[Si](C)(C)C)C(C)C)[Si](C)(C)C1856.9Semi standard non polar33892256
Valylleucine,3TMS,isomer #1CC(C)C[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H](N[Si](C)(C)C)C(C)C)[Si](C)(C)C1928.1Standard non polar33892256
Valylleucine,3TMS,isomer #2CC(C)C[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C1972.3Semi standard non polar33892256
Valylleucine,3TMS,isomer #2CC(C)C[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C1987.0Standard non polar33892256
Valylleucine,3TMS,isomer #3CC(C)C[C@@H](C(=O)O)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C1983.0Semi standard non polar33892256
Valylleucine,3TMS,isomer #3CC(C)C[C@@H](C(=O)O)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C2009.5Standard non polar33892256
Valylleucine,4TMS,isomer #1CC(C)C[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C2049.0Semi standard non polar33892256
Valylleucine,4TMS,isomer #1CC(C)C[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C2093.5Standard non polar33892256
Valylleucine,1TBDMS,isomer #1CC(C)C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)O[Si](C)(C)C(C)(C)C2014.4Semi standard non polar33892256
Valylleucine,1TBDMS,isomer #2CC(C)C[C@H](NC(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)C(=O)O2040.3Semi standard non polar33892256
Valylleucine,1TBDMS,isomer #3CC(C)C[C@@H](C(=O)O)N(C(=O)[C@@H](N)C(C)C)[Si](C)(C)C(C)(C)C2005.5Semi standard non polar33892256
Valylleucine,2TBDMS,isomer #1CC(C)C[C@H](NC(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)C(=O)O[Si](C)(C)C(C)(C)C2282.3Semi standard non polar33892256
Valylleucine,2TBDMS,isomer #1CC(C)C[C@H](NC(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)C(=O)O[Si](C)(C)C(C)(C)C2234.1Standard non polar33892256
Valylleucine,2TBDMS,isomer #2CC(C)C[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H](N)C(C)C)[Si](C)(C)C(C)(C)C2238.2Semi standard non polar33892256
Valylleucine,2TBDMS,isomer #2CC(C)C[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H](N)C(C)C)[Si](C)(C)C(C)(C)C2277.3Standard non polar33892256
Valylleucine,2TBDMS,isomer #3CC(C)C[C@@H](C(=O)O)N(C(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)[Si](C)(C)C(C)(C)C2295.0Semi standard non polar33892256
Valylleucine,2TBDMS,isomer #3CC(C)C[C@@H](C(=O)O)N(C(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)[Si](C)(C)C(C)(C)C2228.8Standard non polar33892256
Valylleucine,2TBDMS,isomer #4CC(C)C[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O2404.4Semi standard non polar33892256
Valylleucine,2TBDMS,isomer #4CC(C)C[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O2257.0Standard non polar33892256
Valylleucine,3TBDMS,isomer #1CC(C)C[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)[Si](C)(C)C(C)(C)C2514.7Semi standard non polar33892256
Valylleucine,3TBDMS,isomer #1CC(C)C[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)[Si](C)(C)C(C)(C)C2488.5Standard non polar33892256
Valylleucine,3TBDMS,isomer #2CC(C)C[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C2641.3Semi standard non polar33892256
Valylleucine,3TBDMS,isomer #2CC(C)C[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C2518.2Standard non polar33892256
Valylleucine,3TBDMS,isomer #3CC(C)C[C@@H](C(=O)O)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2640.4Semi standard non polar33892256
Valylleucine,3TBDMS,isomer #3CC(C)C[C@@H](C(=O)O)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2535.6Standard non polar33892256
Valylleucine,4TBDMS,isomer #1CC(C)C[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2903.8Semi standard non polar33892256
Valylleucine,4TBDMS,isomer #1CC(C)C[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2800.2Standard non polar33892256
Spectra
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
  • Feces
  • Urine
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Normal
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Normal
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Normal
details
UrineDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)BothColorectal Cancer details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Colorectal cancer
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Colorectal cancer
details
Associated Disorders and Diseases
Disease References
Colorectal cancer
  1. Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
  2. Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
  3. Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
Associated OMIM IDs
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDFDB112133
KNApSAcK IDNot Available
Chemspider ID5361221
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound6993117
PDB IDNot Available
ChEBI ID75013
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. De Felice M, Guardiola J, Lamberti A, Iaccarino M: Escherichia coli K-12 mutants altered in the transport systems for oligo- and dipeptides. J Bacteriol. 1973 Nov;116(2):751-6. [PubMed:4126826 ]
  2. Smulson ME, Rabinovitz M, Breitman TR: O-methylthreonine inhibition of growth and of threonine deaminase in Escherichia coli. J Bacteriol. 1967 Dec;94(6):1890-5. [PubMed:4294594 ]